Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
6 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.

Sugary drink consumption may increase risk of cancer

Stephen Padilla
18 Jul 2019
Higher taxes on sugar-sweetened beverages means more resources for healthcare programmes

Drinking sugary beverages may increase the risks of overall cancer and breast cancer, suggests a study. Of note, 100-percent fruit juices also correlate with the risk of overall cancer.

The consumption of sugary drinks significantly correlated with the risks of overall cancer (n=2,193 patients; subdistribution hazard ratio [HR] for a 100-mL/d increase, 1.18, 95 percent CI, 1.10–1.27; p<0.0001) and breast cancer (n=693; HR, 1.22, 1.07–1.39; p=0.004). On the other hand, drinking artificially sweetened beverages did not increase such risks. [BMJ 2019;366:l2408]

Furthermore, specific subanalyses revealed that consumption of 100-percent fruit juices could increase the risk of overall cancer (n=2,193; HR, 1.12, 1.03–1.23; p=0.007).

“These data support the relevance of existing nutritional recommendations to limit sugary drink consumption, including 100-percent fruit juice, as well as policy actions, such as taxation and marketing restrictions targeting sugary drinks, which might potentially contribute to the reduction of cancer incidence,” researchers said. [www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=632; www.wcrf.org/sites/default/files/PPA-Building-Momentum-Report.pdf; BMJ 2016;352:h6704]

The effect of sugary drinks on overweight and obesity onset could partially explain the mechanism behind the increase in cancer risk, especially since excess weight is a strong predictor of mouth, pharynx, larynx, oesophageal (adenocarcinoma), stomach (cardia), pancreatic, gallbladder, liver, colorectal, breast (postmenopause), ovarian, endometrial, prostate (advanced) and kidney cancers. [Int J Obes Relat Metab Disord 2000;24:794-800; Br J Nutr 2011;105:1055-1064; www.wcrf.org/sites/default/files/Summary-third-expert-report.pdf]

In the current study, however, analyses testing different adjustments or stratifications related to body mass index or weight change revealed comparable results, suggesting that overweight and weight gain might not be the only drivers of the association between sugary drinks and cancer risk, researchers said.

While sugar appears to play a significant role, other chemical compounds such as 4-methylimidazole, an additive in drinks that contain caramel colouring or pesticides which could elevate cancer risk and be present in fruit juice, might also contribute to this association. [J Sep Sci 2017;40:3928-3937; J Agric Food Chem 2003;51:6915-6921; Arch Toxicol 2017;91:549-599]

The association of drinking fruit juices with cancer risk could be partly explained by antioxidants that might interact with tobacco smoke to trigger carcinogenesis. However, this hypothesis does not hold water due to the absence of an interaction between fruit juice consumption and smoking status.

“If these results are replicated in further large-scale prospective studies and supported by mechanistic experimental data, and given the large consumption of sugary drinks in Western countries, these beverages would represent a modifiable risk factor for cancer prevention, beyond their well-established impact on cardiometabolic health,” researchers said.

The current study included 101,257 participants aged 18 years from the French NutriNet-Santé cohort (2009–2017). Repeated 24-hour dietary records designed to register participants’ usual consumption for 3,300 different food and beverage items was used to evaluate consumptions of sugary drinks and artificially sweetened beverages.

Multi-adjusted Fine and Gray hazard models, accounting for competing risks, were generated to assess prospective associations of beverage consumptions with the risks of overall, breast, prostate and colorectal cancers. Subdistribution HRs were computed.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 11 Sep 2019

Beta-blockers could reduce mortality risk in patients with heart failure with reduced ejection fraction (HFrEF) and moderate or moderately-severe renal dysfunction without causing harm, according to the BB-META-HF* trial presented at ESC 2019.

Elvira Manzano, 2 days ago

The US Preventive Services Task Force (USPSTF), in an update of its 2013 recommendations, called on clinicians to offer risk-reducing medications to women who are at increased risk for breast cancer but at low risk for adverse effects.

Pearl Toh, 3 days ago
The use of SGLT-2* inhibitors was not associated with a higher risk of severe or nonsevere urinary tract infections (UTIs) in patients with type 2 diabetes (T2D) compared with DPP**-4 inhibitors or GLP-1*** receptor agonists, a population-based cohort study shows.
6 days ago
In type 2 diabetes patients taking sulfonylureas, hypoglycaemia duration is longer at night and is inversely correlated with the level of glycated haemoglobin (HbA1c), a new study reports.